Brief: Senzime Q1 EBITDA at SEK -26.5 Million
28/04/2023 07:32
Apr 28 (Reuters) - Senzime Q1 adjusted gross margin 68.5%. * Q1 sales SEK 7.288 million * Q1 EBITDA SEK -26.461 million
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona